Published in N Engl J Med on March 16, 1995
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81
Current and emerging azole antifungal agents. Clin Microbiol Rev (1999) 5.70
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob Agents Chemother (1996) 3.20
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis (2011) 2.32
Oral candidiasis. Postgrad Med J (2002) 2.02
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol (1999) 1.98
Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell (2007) 1.76
Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis (2007) 1.66
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother (1999) 1.63
Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PLoS One (2013) 1.41
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother (2005) 1.34
Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother (2010) 1.26
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 1.23
Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis (1996) 1.17
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. J Acquir Immune Defic Syndr (2010) 1.13
Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol (1997) 1.10
New Insights into HIV/AIDS-Associated Cryptococcosis. ISRN AIDS (2013) 0.98
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol (2003) 0.97
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl) (2010) 0.92
Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot Cell (2011) 0.92
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Dis Obstet Gynecol (2002) 0.90
Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole. Antimicrob Agents Chemother (1997) 0.90
The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections. Infect Chemother (2016) 0.90
Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana. PLoS Negl Trop Dis (2014) 0.86
Cryptococcal Meningitis in HIV-Infected Patients. Curr Infect Dis Rep (2000) 0.85
Chitinases are essential for sexual development but not vegetative growth in Cryptococcus neoformans. Eukaryot Cell (2009) 0.84
Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis. Future Virol (2013) 0.84
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans. Antimicrob Agents Chemother (2004) 0.81
Candidiasis (oropharyngeal). BMJ Clin Evid (2009) 0.80
HIV: primary and secondary prophylaxis for opportunistic infections. BMJ Clin Evid (2010) 0.79
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection (2013) 0.78
Isolated subcutaneous cryptococcal abscess after a BEACOPP regimen for Hodgkin's lymphoma. Eur J Clin Microbiol Infect Dis (2004) 0.77
In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans. Antimicrob Agents Chemother (1998) 0.77
Treatment and prophylaxis of invasive candidiasis. Semin Perinatol (2012) 0.76
Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study. Genitourin Med (1997) 0.75
Candidiasis (oropharyngeal). BMJ Clin Evid (2013) 0.75
Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus. West J Med (1996) 0.75
Correlation between clinical characteristics and chest computed tomography findings of pulmonary cryptococcosis. Pulm Med (2015) 0.75
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob Agents Chemother (1996) 0.75
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). Infect Dis Obstet Gynecol (2000) 0.75
Mode of Action of a Designed Antimicrobial Peptide: High Potency against Cryptococcus neoformans. Biophys J (2016) 0.75
Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med (1995) 0.75
Candidiasis (oropharyngeal). BMJ Clin Evid (2012) 0.75
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11
Sequence-specific interaction of R17 coat protein with its ribonucleic acid binding site. Biochemistry (1983) 4.09
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron (2000) 3.99
Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr (1997) 3.96
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Patterns of nucleotide misincorporations during enzymatic amplification and direct large-scale sequencing of ancient DNA. Proc Natl Acad Sci U S A (2006) 3.40
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Interaction of R17 coat protein with its RNA binding site for translational repression. J Biomol Struct Dyn (1983) 3.20
Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature (2000) 3.11
Gel retardation. Methods Enzymol (1991) 3.11
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet (1993) 3.03
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med (1993) 2.78
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66
Tandem binding in crystals of a trp repressor/operator half-site complex. Nature (1993) 2.65
The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem (1999) 2.64
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis (1989) 2.51
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med (1999) 2.42
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer (2009) 2.39
Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A (2001) 2.32
Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis (1997) 2.31
Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. Biochemistry (1983) 2.30
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 A. Nature (2001) 2.20
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20
Cultural diversity and informed consent. J Clin Ethics (1998) 2.19
Two forms of autosomal dominant primary retinitis pigmentosa. Doc Ophthalmol (1981) 2.19
Sequence of an HLA-DR alpha-chain cDNA clone and intron-exon organization of the corresponding gene. Nature (1982) 2.18
Kinetic and thermodynamic characterization of the R17 coat protein-ribonucleic acid interaction. Biochemistry (1983) 2.07
CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. Int Endod J (2013) 2.03
Analysis of products of mitochondrial protein synthesis in yeast: genetic and biochemical aspects. Methods Enzymol (1979) 1.96
Photosynthetic and phylogenetic primers for detection of anoxygenic phototrophs in natural environments. Appl Environ Microbiol (2001) 1.93
A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol (1997) 1.92
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity (1998) 1.85
Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. Proc Natl Acad Sci U S A (1983) 1.85
CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84
Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis. Clin Radiol (1999) 1.82
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology (1979) 1.80
Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg (1989) 1.79
Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol (1995) 1.77
Rod sensitivity relative to cone sensitivity in retinitis pigmentosa. Invest Ophthalmol Vis Sci (1979) 1.75
Visual hallucinations in patients with macular degeneration. Am J Psychiatry (1992) 1.75
Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73
Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol (1999) 1.71
Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med (1988) 1.68
Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Ann Intern Med (1990) 1.65
Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol (1998) 1.65
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Prevalence and prediction of hypoxemia in children with respiratory infections in the Peruvian Andes. J Pediatr (1991) 1.62
Pneumocystis carinii pneumonia: a clinical review. Am Fam Physician (1999) 1.61
Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res (2002) 1.60
Translation activates the paused transcription complex and restores transcription of the trp operon leader region. Proc Natl Acad Sci U S A (1985) 1.59
The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development (1999) 1.59
Adams-Stokes syndrome due to sinoatrial block. Am J Cardiol (1966) 1.58
Persistence of high-risk sexual activity among homosexual men in an area of low incidence of the acquired immunodeficiency syndrome. Sex Transm Dis (1987) 1.57
Motor cortical representation of the pelvic floor muscles. J Urol (2011) 1.56
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med (1992) 1.53
Visual acuity loss in retinitis pigmentosa. Relationship to visual field loss. Arch Ophthalmol (1990) 1.52
Solution structure of the DNA-binding domain and model for the complex of multifunctional hexameric arginine repressor with DNA. Nat Struct Biol (1997) 1.52
Central nervous system bleeding in hemophiliacs. Blood (1978) 1.51
Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50
Study of the distribution of non-point source pollution in the watershed of the Miyun Reservoir, Beijing, China. Water Sci Technol (2001) 1.49
Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood (1990) 1.49
Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol (1982) 1.48
In vivo proton MRS of normal pancreas metabolites during breath-holding and free-breathing. Clin Radiol (2012) 1.48
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS (2000) 1.48
Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses (1987) 1.44
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol (1990) 1.43
Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod (2007) 1.42
Prediction and confirmation of a site critical for effector regulation of RGS domain activity. Nat Struct Biol (2001) 1.42
Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med (1983) 1.41
Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis (2000) 1.41
Two highly homologous putative DNA-binding proteins in yeast and E. coli. Trends Biochem Sci (1994) 1.41
Laboratory investigation of ecological factors influencing the environmental presence of Burkholderia pseudomallei. Microbiol Immunol (1996) 1.40
Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw? Ir Med J (2008) 1.39
Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol (1991) 1.39
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis (1991) 1.37
Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci (1999) 1.37
Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet (1988) 1.36
Ordered self-assembly of polypeptide fragments to form nativelike dimeric trp repressor. Science (1992) 1.36
Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35
Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys (1997) 1.33
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis (2001) 1.32
Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics (1996) 1.31
Cell-specific expression of tubby gene family members (tub, Tulp1,2, and 3) in the retina. Invest Ophthalmol Vis Sci (1999) 1.31
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1993) 1.31